GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViroGates A/S (OCSE:VIRO) » Definitions » Ending Cash Position

ViroGates A/S (OCSE:VIRO) Ending Cash Position : kr12.23 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is ViroGates A/S Ending Cash Position?

ViroGates A/S's Ending Cash Position for the quarter that ended in Mar. 2024 was kr12.23 Mil.

ViroGates A/S's quarterly Ending Cash Position increased from Sep. 2023 (kr6.42 Mil) to Dec. 2023 (kr16.03 Mil) but then declined from Dec. 2023 (kr16.03 Mil) to Mar. 2024 (kr12.23 Mil).

ViroGates A/S's annual Ending Cash Position declined from Dec. 2021 (kr14.86 Mil) to Dec. 2022 (kr9.88 Mil) but then increased from Dec. 2022 (kr9.88 Mil) to Dec. 2023 (kr16.03 Mil).


ViroGates A/S Ending Cash Position Historical Data

The historical data trend for ViroGates A/S's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViroGates A/S Ending Cash Position Chart

ViroGates A/S Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial 41.41 33.53 14.86 9.88 16.03

ViroGates A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.46 8.55 6.42 16.03 12.23

ViroGates A/S Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

ViroGates A/S's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=9.879+6.148
=16.03

ViroGates A/S's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=16.027+-3.798
=12.23


ViroGates A/S Ending Cash Position Related Terms

Thank you for viewing the detailed overview of ViroGates A/S's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


ViroGates A/S (OCSE:VIRO) Business Description

Traded in Other Exchanges
N/A
Address
Banevaenget 13, Birkerod, DNK, DK-3460
ViroGates A/S is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

ViroGates A/S (OCSE:VIRO) Headlines

No Headlines